With my first hand experience I cannot recommend that Dr Walitt lead the clinical part of the critically important ME/CFS study. Dr. Collins and Dr. Nath need to reevaluate and reconsider. Dr Walitt is too biased and inexperienced. He doesn't follow the science. I have had over 20 years of experience volunteering as a clinical research subject for both FM and ME/CFS. Thank you.
I appreciate the courage, use of energy, and time to communicate your experience to Cort Johnson, and when that failed to be included in his article, you took the time to report it here. This is very important. Thank you so much.
Even if Walitt is not in charge of the study, the protocol, etc... He is still having possible patient contact, organizing tests at the clinic, may even be obtaining the answers to questionnaires and tasked with collating them.
I just don't see how any involvement in the study should be allowed.
In addition, that he was given lead position in the large group of investigators, and clinical investigator is concerning. Walitt's credentials would have been looked at, his history known. Whoever selected him and Fred Gills was complicit; which brings into question the motives of that individual(s). And to follow that up with the justifications from NIH personnel, on why he still remains part of the study, is equally troubling.
Now, some advocates want to wait to hear what NIH officials will say to Carol Head and Mary Dimmock when they speak with them next week; one subject matter being the continued inclusion of Walitt in the study.
So I will have to take that NIH officials means NIH Trans-Working Group and it's leader Dr. Koroshetz [my original comment said Carol and Mary were meeting with Collins. I misread a quote... it said NIH officials, so this comment has been updated.]
In addition, Collins has not responded to the petition of 725 advocates (
http://www.meadvocacy.org/follow_up_reminder_email_to_collins) and patients wanting a stop to the study. And there has been no response since 02/15/2016.